Neuroprotective effects of leptin following kainic acid-induced status epilepticus

Epilepsy and Behavior

Volumn 19, Issue 3, 2010, Pages 278-283

  Obeid, Makram ^a,b   Frank, Jeffrey ^a   Medina, Margarita ^a   Finckbone, VelvetLee ^a   Bliss, Richard ^a   Bista, Binod ^a   Majmudar, Shirine ^a   Hurst, Daniel ^a   Strahlendorf, Howard ^a   Strahlendorf, Jean ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b College of Physicians and Surgeons Columbia University ^*  (United States)

Author keywords

Behavioral deficits; Epileptogenesis; Leptin; Memory; Neuroprotection; Status epilepticus

Indexed keywords

KAINIC ACID; LEPTIN;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; EPILEPTIC STATE; HIPPOCAMPUS; HISTOLOGY; HYPERACTIVITY; LONG TERM CARE; MALE; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PYRAMIDAL NERVE CELL; RAT; SHAM PROCEDURE; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; CELL COUNT; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; HIPPOCAMPUS; KAINIC ACID; LEPTIN; MALE; NEUROPROTECTIVE AGENTS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS;

EID: 78649905807     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.07.023     Document Type: Article

References (24)

1. Naegele J.R. Neuroprotective strategies to avert seizure-induced neurodegeneration in epilepsy. Epilepsia 2007, 48(Suppl. 2):107-117.
2. Francois J., Koning E., Ferrandon A., Nehlig A. The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res 2006, 72:147-163.
3. Bolanos A.R., Sarkisian M., Yang Y., et al. Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology 1998, 51:41-48.
4. Cilio M.R., Bolanos A.R., Liu Z., et al. Anticonvulsant action and long-term effects of gabapentin in the immature brain. Neuropharmacology 2001, 40:139-147.
5. Pitkanen A., Kharatishvili I., Narkilahti S., Lukasiuk K., Nissinen J. Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat. Epilepsy Res 2005, 63:27-42.
6. Muller-Schwarze A.B., Tandon P., Liu Z., Yang Y., Holmes G.L., Stafstrom C.E. Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model. NeuroReport 1999, 10:1517-1522.
7. Nadam J., Navarro F., Sanchez P., et al. Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol Dis 2007, 25:412-426.
8. Liu Z., D'Amore P.A., Mikati M., Gatt A., Holmes G.L. Neuroprotective effect of chronic infusion of basic fibroblast growth factor on seizure-associated hippocampal damage. Brain Res 1993, 626:335-338.
9. Wang Q., Yu S., Simonyi A., Rottinghaus G., Sun G.Y., Sun A.Y. Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem Res 2004, 29:2105-2112.
10. Suchomelova L., Baldwin R.A., Kubova H., Thompson K.W., Sankar R., Wasterlain C.G. Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects. Pediatr Res 2006, 59:237-243.
11. Harvey J. Leptin: a multifaceted hormone in the central nervous system. Mol Neurobiol 2003, 28:245-258.
12. Signore A.P., Zhang F., Weng Z., Gao Y., Chen J. Leptin neuroprotection in the CNS: mechanisms and therapeutic potentials. J Neurochem 2008, 106:1977-1990.
13. Dicou E., Attoub S., Gressens P. Neuroprotective effects of leptin in vivo and in vitro. NeuroReport 2001, 12:3947-3951.
14. Mikati M.A., Abi-Habib R.J., El Sabban M.E., et al. Hippocampal programmed cell death after status epilepticus: evidence for NMDA-receptor and ceramide-mediated mechanisms. Epilepsia 2003, 44:282-291.
15. Erbayat-Altay E., Yamada K.A., Wong M., Thio L.L. Increased severity of pentylenetetrazol induced seizures in leptin deficient ob/ob mice. Neurosci Lett 2008, 433:82-86.
16. Guo Z., Jiang H., Xu X., Duan W., Mattson M.P. Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization. J Biol Chem 2008, 283:1754-1763.
17. Stafstrom C.E., Chronopoulos A., Thurber S., Thompson J.L., Holmes G.L. Age-dependent cognitive and behavioral deficits after kainic acid seizures. Epilepsia 1993, 34:420-432.
18. Zhang F., Wang S., Signore A.P., Chen J. Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia. Stroke 2007, 38:2329-2336.
19. Campfield L.A., Smith F.J., Guisez Y., Devos R., Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995, 269:546-549.
20. Sperk G., Lassmann H., Baran H., Kish S.J., Seitelberger F., Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 1983, 10:1301-1315.
21. Coles J., Oomman S.K., Henne W.M., et al. AMPA-induced dark cell degeneration is associated with activation of caspases in pyramidal neurons of the rat hippocampus. Neurosci Lett 2008, 436:294-299.
22. Ayyildiz M., Yildirim M., Agar E., Baltaci A.K. The effect of leptin on penicillin-induced epileptiform activity in rats. Brain Res Bull 2006, 68:374-378.
23. Trimble M.R., Thompson P.J. Memory, anticonvulsant drugs and seizures. Acta Neurol Scand Suppl 1981, 89:31-41.
24. Li X.L., Aou S., Oomura Y., Hori N., Fukunaga K., Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 2002, 113:607-615.